{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2025,9,28]],"date-time":"2025-09-28T10:55:44Z","timestamp":1759056944888},"reference-count":60,"publisher":"Elsevier BV","issue":"2","license":[{"start":{"date-parts":[[2014,10,1]],"date-time":"2014-10-01T00:00:00Z","timestamp":1412121600000},"content-version":"tdm","delay-in-days":0,"URL":"https:\/\/www.elsevier.com\/tdm\/userlicense\/1.0\/"}],"funder":[{"DOI":"10.13039\/100010269","name":"Wellcome Trust of England","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100010269","id-type":"DOI","asserted-by":"crossref"}]},{"name":"Kentucky Spinal Cord"},{"name":"Head Injury Research Trust, Kentucky, USA"},{"DOI":"10.13039\/501100000925","name":"National Health & Medical Research Council of Australia (NHMRC)","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000925","id-type":"DOI","asserted-by":"publisher"}]},{"DOI":"10.13039\/501100000923","name":"Australian Research Council","doi-asserted-by":"publisher","id":[{"id":"10.13039\/501100000923","id-type":"DOI","asserted-by":"publisher"}]}],"content-domain":{"domain":["elsevier.com","sciencedirect.com"],"crossmark-restriction":true},"short-container-title":["Molecular Immunology"],"published-print":{"date-parts":[[2014,10]]},"DOI":"10.1016\/j.molimm.2014.06.022","type":"journal-article","created":{"date-parts":[[2014,7,19]],"date-time":"2014-07-19T21:45:16Z","timestamp":1405806316000},"page":"204-209","update-policy":"http:\/\/dx.doi.org\/10.1016\/elsevier_cm_policy","source":"Crossref","is-referenced-by-count":5,"title":["Exploring the potential benefits of vaccinia virus complement control protein in controlling complement activation in pathogenesis of the central nervous system diseases"],"prefix":"10.1016","volume":"61","author":[{"given":"Girish J.","family":"Kotwal","sequence":"first","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Nilisha","family":"Fernando","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Jianhua","family":"Zhou","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]},{"given":"Krisztina","family":"Valter","sequence":"additional","affiliation":[],"role":[{"role":"author","vocabulary":"crossref"}]}],"member":"78","reference":[{"issue":"2","key":"10.1016\/j.molimm.2014.06.022_bib0005","doi-asserted-by":"crossref","first-page":"389","DOI":"10.1111\/j.1471-4159.2010.06595.x","article-title":"Microglial C5aR (CD88) expression correlates with amyloid-beta deposition in murine models of Alzheimer's disease","volume":"113","author":"Ager","year":"2010","journal-title":"J. Neurochem."},{"issue":"5","key":"10.1016\/j.molimm.2014.06.022_bib0010","doi-asserted-by":"crossref","first-page":"1169","DOI":"10.1111\/j.1471-4159.2008.05668.x","article-title":"The complement cascade: Yin-Yang in neuroinflammation\u2013neuro-protection and -degeneration","volume":"107","author":"Alexander","year":"2008","journal-title":"J. Neurochem."},{"issue":"4","key":"10.1016\/j.molimm.2014.06.022_bib0015","doi-asserted-by":"crossref","first-page":"1083","DOI":"10.1016\/S0041-1345(02)02805-1","article-title":"Vaccinia virus complement control protein inhibits hyperacute xenorejection","volume":"34","author":"Anderson","year":"2002","journal-title":"Transplant. Proc."},{"key":"10.1016\/j.molimm.2014.06.022_bib0020","doi-asserted-by":"crossref","first-page":"535","DOI":"10.2147\/CIA.S51571","article-title":"The genetics of Alzheimer's disease","volume":"9","author":"Bagyinszky","year":"2014","journal-title":"Clin. Interv. Aging"},{"key":"10.1016\/j.molimm.2014.06.022_bib0025","doi-asserted-by":"crossref","first-page":"33","DOI":"10.1016\/j.molimm.2006.06.021","article-title":"Complement proteins C1q and MBL are pattern recognition molecules that signal immediate and long-term protective immune functions","volume":"44","author":"Bohlson","year":"2007","journal-title":"Mol. Immunol."},{"issue":"1","key":"10.1016\/j.molimm.2014.06.022_bib0035","doi-asserted-by":"crossref","first-page":"45","DOI":"10.5607\/en.2014.23.1.45","article-title":"Alzheimer's disease and stem cell therapy","volume":"23","author":"Choi","year":"2014","journal-title":"Exp. Neurobiol."},{"key":"10.1016\/j.molimm.2014.06.022_bib0040","first-page":"983640","article-title":"Microglia Alzheimer's disease, and complement","volume":"2012","author":"Crehan","year":"2012","journal-title":"Int. J. Alzheimers Dis."},{"issue":"12","key":"10.1016\/j.molimm.2014.06.022_bib0045","doi-asserted-by":"crossref","first-page":"1786","DOI":"10.1016\/j.neurobiolaging.2005.10.016","article-title":"Microvascular pathology in the aging human brain: evidence that senile plaques are sites of microhaemorrhages","volume":"27","author":"Cullen","year":"2006","journal-title":"Neurobiol. Aging"},{"issue":"6 (Nov\u2013Dec)","key":"10.1016\/j.molimm.2014.06.022_bib0050","doi-asserted-by":"crossref","first-page":"619","DOI":"10.1016\/S0197-4580(98)00100-6","article-title":"Pro-inflammatory complement activation by the A beta peptide of Alzheimer's disease is biologically significant and can be blocked by vaccinia virus complement control protein","volume":"19","author":"Daly","year":"1998","journal-title":"Neurobiol. Aging"},{"issue":"1\u20132","key":"10.1016\/j.molimm.2014.06.022_bib0055","doi-asserted-by":"crossref","first-page":"208","DOI":"10.1016\/j.ijpharm.2007.04.031","article-title":"Poly(D l-lactide-co-glycolide) (PLGA) nanoparticles prepared by high pressure homogenization for paclitaxel chemotherapy","volume":"342","author":"Dong","year":"2007","journal-title":"Int. J. Pharm."},{"issue":"5720 (Apr)","key":"10.1016\/j.molimm.2014.06.022_bib0060","doi-asserted-by":"crossref","first-page":"421","DOI":"10.1126\/science.1110189","article-title":"Complement factor H polymorphism and age-related macular degeneration","volume":"308","author":"Edwards","year":"2005","journal-title":"Science"},{"key":"10.1016\/j.molimm.2014.06.022_bib0065","doi-asserted-by":"crossref","first-page":"22","DOI":"10.1186\/1742-2094-4-22","article-title":"Induction of complement proteins in a mouse model for cerebral microvascular A beta deposition","volume":"4","author":"Fan","year":"2007","journal-title":"J. Neuroinflammation"},{"issue":"2","key":"10.1016\/j.molimm.2014.06.022_bib0070","doi-asserted-by":"crossref","first-page":"1375","DOI":"10.4049\/jimmunol.0901005","article-title":"Treatment with a C5aR antagonist decreases pathology and enhances behavioral performance in murine models of Alzheimer's disease","volume":"183","author":"Fonseca","year":"2009","journal-title":"J. Immunol."},{"key":"10.1016\/j.molimm.2014.06.022_bib0075","series-title":"Unites States Patent Application Publication Pub. No. US 2006\/0142191 A1","article-title":"Viral complement control proteins for eye disorders","author":"Francois","year":"2006"},{"key":"10.1016\/j.molimm.2014.06.022_bib0080","doi-asserted-by":"crossref","first-page":"171","DOI":"10.1016\/S0162-3109(00)80302-1","article-title":"Complement components of the innate immune system in health and disease in the CNS","volume":"49","author":"Gasque","year":"2000","journal-title":"Immunopharmacology"},{"issue":"7 (Jul)","key":"10.1016\/j.molimm.2014.06.022_bib0085","doi-asserted-by":"crossref","first-page":"793","DOI":"10.1038\/sj.ejhg.5201431","article-title":"A new vision for age-related macular degeneration","volume":"13","author":"Gorin","year":"2005","journal-title":"Eur. J. Hum. Genet."},{"issue":"116","key":"10.1016\/j.molimm.2014.06.022_bib0090","doi-asserted-by":"crossref","first-page":"96","DOI":"10.1016\/j.exer.2013.07.023","article-title":"Novel compstatin family peptides inhibit complement activation by drusen-like deposits in human retinal pigmented epithelial cell cultures","volume":"2013","author":"Gorham","year":"2013","journal-title":"Exp. Eye Res."},{"issue":"4 (Apr)","key":"10.1016\/j.molimm.2014.06.022_bib0095","doi-asserted-by":"crossref","first-page":"458","DOI":"10.1038\/ng1750","article-title":"Variation in factor B (BF) and complement component 2 (C2) genes is associated with age-related macular degeneration","volume":"38","author":"Gold","year":"2006","journal-title":"Nat. Genet."},{"issue":"20 (May)","key":"10.1016\/j.molimm.2014.06.022_bib0100","doi-asserted-by":"crossref","first-page":"7227","DOI":"10.1073\/pnas.0501536102","article-title":"A common haplotype in the complement regulatory gene factor H (HF1\/CFH) predisposes individuals to age-related macular degeneration","volume":"102","author":"Hageman","year":"2005","journal-title":"Proc. Nat. Acad. Sci. U.S.A."},{"issue":"5720 (Apr)","key":"10.1016\/j.molimm.2014.06.022_bib0105","doi-asserted-by":"crossref","first-page":"419","DOI":"10.1126\/science.1110359","article-title":"Complement factor H variant increases the risk of age-related macular degeneration","volume":"308","author":"Haines","year":"2005","journal-title":"Science"},{"issue":"6","key":"10.1016\/j.molimm.2014.06.022_bib0110","doi-asserted-by":"crossref","first-page":"705","DOI":"10.1089\/08977150260139093","article-title":"Vaccinia virus complement control protein enhances functional recovery after traumatic brain injury","volume":"19","author":"Hicks","year":"2002","journal-title":"J. Neurotrauma"},{"issue":"4","key":"10.1016\/j.molimm.2014.06.022_bib0115","doi-asserted-by":"crossref","first-page":"1606","DOI":"10.1016\/S0041-1345(03)00485-8","article-title":"\u201cDose-dependent inhibition of complement in baboons by vaccinia virus complement control protein: implications in xenotransplantation","volume":"35","author":"Kahn","year":"2003","journal-title":"Transplant. Proc."},{"issue":"308 (Apr)","key":"10.1016\/j.molimm.2014.06.022_bib0120","doi-asserted-by":"crossref","first-page":"385","DOI":"10.1126\/science.1109557","article-title":"Complement factor H polymorphism in age-related macular degeneration","volume":"15","author":"Klein","year":"2005","journal-title":"Science"},{"issue":"7","key":"10.1016\/j.molimm.2014.06.022_bib0125","doi-asserted-by":"crossref","first-page":"753","DOI":"10.1021\/cb2000378","article-title":"Synthesis and activity of thioether-containing analogues of the complement inhibitor compstatin","volume":"6","author":"Knerr","year":"2011","journal-title":"ACS Chem. Biol."},{"issue":"10","key":"10.1016\/j.molimm.2014.06.022_bib0130","first-page":"76","article-title":"Purification of virokines using ultrafiltration","volume":"12","author":"Kotwal","year":"1994","journal-title":"Am. Biotechnol. Lab."},{"issue":"4982","key":"10.1016\/j.molimm.2014.06.022_bib0135","doi-asserted-by":"crossref","first-page":"827","DOI":"10.1126\/science.2237434","article-title":"Inhibition of the complement cascade by the major secretory protein of vaccinia virus","volume":"250","author":"Kotwal","year":"1990","journal-title":"Science"},{"issue":"6186","key":"10.1016\/j.molimm.2014.06.022_bib0140","doi-asserted-by":"crossref","first-page":"176","DOI":"10.1038\/335176a0","article-title":"Vaccinia virus encodes a secretory polypeptide structurally related to complement control proteins","volume":"335","author":"Kotwal","year":"1988","journal-title":"Nature"},{"issue":"4 (Oct)","key":"10.1016\/j.molimm.2014.06.022_bib0145","doi-asserted-by":"crossref","first-page":"415","DOI":"10.1002\/jlb.62.4.415","article-title":"Microorganisms and their interaction with the immune system","volume":"62","author":"Kotwal","year":"1997","journal-title":"J. Leukoc. Biol."},{"issue":"1 (Feb)","key":"10.1016\/j.molimm.2014.06.022_bib0155","doi-asserted-by":"crossref","first-page":"32","DOI":"10.2174\/156720511794604615","article-title":"Complement-initiated neuroinflammation and its role in early stage Alzheimer's disease. Commentary","volume":"8","author":"Kotwal","year":"2011","journal-title":"Curr. Alzheimer Res."},{"issue":"15","key":"10.1016\/j.molimm.2014.06.022_bib0160","doi-asserted-by":"crossref","first-page":"1841","DOI":"10.1001\/jama.293.15.1841","article-title":"Gene discovery provides clues to cause of age-related macular degeneration","volume":"293","author":"Kuehn","year":"2005","journal-title":"JAMA"},{"issue":"1","key":"10.1016\/j.molimm.2014.06.022_bib0165","doi-asserted-by":"crossref","first-page":"95","DOI":"10.2174\/156720511794604598","article-title":"Modulation of anxiety behavior by intranasally administered vaccinia virus complement control protein and curcumin in a mouse model of Alzheimer's disease","volume":"8","author":"Kulkarni","year":"2011","journal-title":"Curr. Alzheimer Res."},{"issue":"6","key":"10.1016\/j.molimm.2014.06.022_bib0170","doi-asserted-by":"crossref","first-page":"405","DOI":"10.1007\/s10522-008-9161-7","article-title":"Intracranial administration of vaccinia virus complement control protein in Mo\/Hu APPswe PS1dE9 transgenic mice at an early age shows enhanced performance at a later age using a cheese board maze test","volume":"9","author":"Kulkarni","year":"2008","journal-title":"Biogerontology"},{"key":"10.1016\/j.molimm.2014.06.022_bib0175","doi-asserted-by":"crossref","first-page":"305","DOI":"10.1007\/978-1-61779-876-4_18","article-title":"Central nervous system distribution of the poxviral proteins after intranasal administration of proteins and titering of vaccinia virus in the brain after intracranial administration","volume":"890","author":"Kulkarni","year":"2012","journal-title":"Methods Mol. Biol."},{"issue":"5 (Sep)","key":"10.1016\/j.molimm.2014.06.022_bib0180","doi-asserted-by":"crossref","first-page":"565","DOI":"10.1586\/17512433.2013.829645","article-title":"Update on current and future novel therapies for dry age-related macular degeneration","volume":"6","author":"Leung","year":"2013","journal-title":"Expert Rev. Clin. Pharmacol."},{"issue":"2 (Feb)","key":"10.1016\/j.molimm.2014.06.022_bib0185","doi-asserted-by":"crossref","first-page":"106","DOI":"10.1038\/nrneurol.2012.263","article-title":"Apolipoprotein E and Alzheimer disease: risk, mechanisms and therapy","volume":"9","author":"Liu","year":"2013","journal-title":"Nat. Rev. Neurol."},{"issue":"1","key":"10.1016\/j.molimm.2014.06.022_bib0190","doi-asserted-by":"crossref","first-page":"11","DOI":"10.1007\/s12035-012-8234-4","article-title":"Regulation of complement factor H (CFH) by multiple miRNAs in Alzheimer's disease (AD) brain","volume":"46","author":"Lukiw","year":"2012","journal-title":"Mol. Neurobiol."},{"issue":"5 (Dec)","key":"10.1016\/j.molimm.2014.06.022_bib0195","doi-asserted-by":"crossref","first-page":"871","DOI":"10.1016\/j.neuron.2012.11.020","article-title":"Apolipoprotein e sets the stage: response to injury triggers neuropathology","volume":"76","author":"Mahley","year":"2012","journal-title":"Neuron"},{"key":"10.1016\/j.molimm.2014.06.022_bib0200","doi-asserted-by":"crossref","first-page":"135","DOI":"10.1016\/S0006-8993(96)01324-8","article-title":"Apolipoprotein (Apo E4 but not Apo E or Apo E2 potentiates Beta amyloid protein activation of complement in vitro","volume":"749","author":"McGeer","year":"1997","journal-title":"Brain Res."},{"issue":"7 (May)","key":"10.1016\/j.molimm.2014.06.022_bib0205","doi-asserted-by":"crossref","first-page":"835","DOI":"10.1096\/fasebj.14.7.835","article-title":"Drusen associated with aging and age-related macular degeneration contain proteins common to extracellular deposits associated with atherosclerosis, elastosis, amyloidosis, and dense deposit disease","volume":"14","author":"Mullins","year":"2000","journal-title":"FASEB J."},{"issue":"2","key":"10.1016\/j.molimm.2014.06.022_bib0210","doi-asserted-by":"crossref","first-page":"301","DOI":"10.1016\/S0092-8674(01)00214-8","article-title":"Crystal structure of a complement control protein that regulates both pathways of complement activation and binds heparan sulfate proteoglycans","volume":"104","author":"Murthy","year":"2001","journal-title":"Cell"},{"issue":"4","key":"10.1016\/j.molimm.2014.06.022_bib0215","doi-asserted-by":"crossref","first-page":"295","DOI":"10.2174\/1567205043331965","article-title":"Molecular mechanisms, emerging etiological insights and models to test potential therapeutic interventions in Alzheimer's disease","volume":"1","author":"Pillay","year":"2004","journal-title":"Curr. Alzheimer Res."},{"key":"10.1016\/j.molimm.2014.06.022_bib0220","doi-asserted-by":"crossref","first-page":"158","DOI":"10.1016\/j.brainres.2007.03.056","article-title":"Vaccinia virus complement control protein significantly improves sensorimotor function recovery after severe head trauma","volume":"1153","author":"Pillay","year":"2007","journal-title":"Brain Res."},{"issue":"2","key":"10.1016\/j.molimm.2014.06.022_bib0225","doi-asserted-by":"crossref","first-page":"173","DOI":"10.1016\/j.bbr.2008.03.038","article-title":"Early detection of memory deficits and memory improvement with vaccinia virus complement control protein in an Alzheimer's disease model","volume":"192","author":"Pillay","year":"2008","journal-title":"Behav. Brain Res."},{"key":"10.1016\/j.molimm.2014.06.022_bib0230","first-page":"273","article-title":"Compstatin: a complement inhibitor on its way to clinical application","volume":"632","author":"Ricklin","year":"2008","journal-title":"Adv. Exp. Med. Biol."},{"key":"10.1016\/j.molimm.2014.06.022_bib0235","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1196\/annals.1332.011","article-title":"Vaccinia virus complement control protein reduces inflammation and improves spinal cord integrity following spinal cord injury","volume":"1035","author":"Reynolds","year":"2004","journal-title":"Ann. N.Y. Acad. Sci."},{"issue":"21","key":"10.1016\/j.molimm.2014.06.022_bib0240","doi-asserted-by":"crossref","first-page":"10016","DOI":"10.1073\/pnas.89.21.10016","article-title":"Complement activation by beta-amyloid in Alzheimer disease","volume":"89","author":"Rogers","year":"1992","journal-title":"Proc. Nat. Acad. Sci. U.S.A."},{"issue":"8 (Jul)","key":"10.1016\/j.molimm.2014.06.022_bib0245","doi-asserted-by":"crossref","first-page":"5347","DOI":"10.1167\/iovs.10-7119","article-title":"Analysis of complement expression in light-induced retinal degeneration: synthesis and deposition of C3 by microglia\/macrophages is associated with focal photoreceptor degeneration","volume":"52","author":"Rutar","year":"2011","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"5","key":"10.1016\/j.molimm.2014.06.022_bib0250","doi-asserted-by":"crossref","first-page":"2379","DOI":"10.1167\/iovs.10-6010","article-title":"Early focal expression of the chemokine Ccl2 by M\u00fcller cells during exposure to damage-inducing bright continuous light","volume":"52","author":"Rutar","year":"2011","journal-title":"Invest. Ophthalmol. Vis. Sci."},{"issue":"7","key":"10.1016\/j.molimm.2014.06.022_bib0255","doi-asserted-by":"crossref","first-page":"631","DOI":"10.3109\/02713681003682925","article-title":"Brief exposure to damaging light causes focal recruitment of macrophages, and long-term destabilization of photoreceptors in the albino rat retina","volume":"35","author":"Rutar","year":"2010","journal-title":"Curr. Eye Res."},{"issue":"2","key":"10.1016\/j.molimm.2014.06.022_bib0260","doi-asserted-by":"crossref","first-page":"177","DOI":"10.1016\/S0896-6273(01)00475-5","article-title":"Clearing the brain's amyloid cobwebs","volume":"32","author":"Selkoe","year":"2001","journal-title":"Neuron"},{"issue":"2 (Jul)","key":"10.1016\/j.molimm.2014.06.022_bib0265","article-title":"SnapShot: pathobiology of Alzheimer's disease","volume":"154","author":"Selkoe","year":"2013","journal-title":"Cell"},{"issue":"3","key":"10.1016\/j.molimm.2014.06.022_bib0270","doi-asserted-by":"crossref","first-page":"165","DOI":"10.1016\/S0304-3940(01)01842-0","article-title":"Complement activation by neurofibrillary tangles in Alzheimer's disease","volume":"305","author":"Shen","year":"2001","journal-title":"Neurosci. Lett."},{"issue":"2","key":"10.1016\/j.molimm.2014.06.022_bib0275","doi-asserted-by":"crossref","first-page":"362","DOI":"10.1006\/exnr.1999.7170","article-title":"Increased complement biosynthesis by microglia and complement activation on neurons in Huntington's disease","volume":"159","author":"Singhrao","year":"1999","journal-title":"Exp. Neurol."},{"issue":"1\u20132","key":"10.1016\/j.molimm.2014.06.022_bib0280","doi-asserted-by":"crossref","first-page":"55","DOI":"10.1016\/S0167-4838(02)00339-4","article-title":"Vaccinia virus complement control protein is monomeric, and retains structural and functional integrity after exposure to adverse conditions","volume":"1598","author":"Smith","year":"2002","journal-title":"Biochim. Biophys. Acta"},{"issue":"12","key":"10.1016\/j.molimm.2014.06.022_bib0285","doi-asserted-by":"crossref","first-page":"5659","DOI":"10.1128\/JVI.74.12.5659-5666.2000","volume":"74","author":"Smith","year":"2000","journal-title":"J. Virol."},{"issue":"33","key":"10.1016\/j.molimm.2014.06.022_bib0290","doi-asserted-by":"crossref","first-page":"13460","DOI":"10.1523\/JNEUROSCI.1333-13.2013","article-title":"A dramatic increase of C1q protein in the CNS during normal aging","volume":"33","author":"Stephan","year":"2013","journal-title":"J. Neurosci."},{"issue":"5 (May)","key":"10.1016\/j.molimm.2014.06.022_bib0295","doi-asserted-by":"crossref","first-page":"703","DOI":"10.1111\/j.1747-0285.2012.01324.x","article-title":"Molecular dynamics in drug design: new generations of compstatin analogs","volume":"79","author":"Tamamis","year":"2012","journal-title":"Chem. Biol. Drug Des."},{"issue":"1","key":"10.1016\/j.molimm.2014.06.022_bib0300","doi-asserted-by":"crossref","first-page":"34","DOI":"10.2174\/156720511794604589","article-title":"Histological and direct evidence for the role of complement in the neuroinflammation of AD","volume":"8","author":"Veerhuis","year":"2011","journal-title":"Curr. Alzheimer Res."},{"issue":"5","key":"10.1016\/j.molimm.2014.06.022_bib0310","doi-asserted-by":"crossref","first-page":"2080","DOI":"10.1111\/j.1471-4159.2008.05558.x","article-title":"Complement C3 and C4 expression in C1q sufficient and deficient mouse models of Alzheimer's disease","volume":"106","author":"Zhou","year":"2008","journal-title":"J. Neurochem."},{"issue":"4 (Apr)","key":"10.1016\/j.molimm.2014.06.022_bib0315","doi-asserted-by":"crossref","first-page":"440","DOI":"10.1001\/jamaneurol.2013.2152","article-title":"Cerebrovascular effects of apolipoprotein E: implications for Alzheimer disease","volume":"70","author":"Zlokovic","year":"2013","journal-title":"JAMA Neurol."}],"container-title":["Molecular Immunology"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589014001539?httpAccept=text\/plain","content-type":"text\/plain","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.elsevier.com\/content\/article\/PII:S0161589014001539?httpAccept=text\/xml","content-type":"text\/xml","content-version":"vor","intended-application":"text-mining"}],"deposited":{"date-parts":[[2020,5,12]],"date-time":"2020-05-12T02:49:56Z","timestamp":1589251796000},"score":1,"resource":{"primary":{"URL":"https:\/\/linkinghub.elsevier.com\/retrieve\/pii\/S0161589014001539"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2014,10]]},"references-count":60,"journal-issue":{"issue":"2","published-print":{"date-parts":[[2014,10]]}},"alternative-id":["S0161589014001539"],"URL":"https:\/\/doi.org\/10.1016\/j.molimm.2014.06.022","relation":{},"ISSN":["0161-5890"],"issn-type":[{"type":"print","value":"0161-5890"}],"subject":[],"published":{"date-parts":[[2014,10]]},"assertion":[{"value":"Elsevier","name":"publisher","label":"This article is maintained by"},{"value":"Exploring the potential benefits of vaccinia virus complement control protein in controlling complement activation in pathogenesis of the central nervous system diseases","name":"articletitle","label":"Article Title"},{"value":"Molecular Immunology","name":"journaltitle","label":"Journal Title"},{"value":"https:\/\/doi.org\/10.1016\/j.molimm.2014.06.022","name":"articlelink","label":"CrossRef DOI link to publisher maintained version"},{"value":"article","name":"content_type","label":"Content Type"},{"value":"Copyright \u00a9 2014 Elsevier Ltd. All rights reserved.","name":"copyright","label":"Copyright"}]}}